MYO - Myomo Inc.: In Motion To Accelerating Revenue Growth March, 10 2024 03:00 AM Myomo Inc. 2024-03-10 03:00:22 ET Summary Medicare decision created a multi-decade revenue growth opportunity. Soft Q1 guidance due to non-recurring timing issues. 2024 guidance gives only partial-year credit to reimbursement change. MYO revenue growth is poised to accelerate further in 2025. Background For further details see: Myomo, Inc.: In Motion To Accelerating Revenue Growth